News Center

PRICARAÂ®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc

Following are recent news releases issued by PriCara^®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

For additional media resources, click here.

01/14/10

PRICARA^® is dedicated to Primary Care - helping healthcare professionals meet their patients' needs. It's called Health Care

06/23/09

NUCYNTA™ (TAPENTADOL) CII IMMEDIATE RELEASE TABLETS NOW AVAILABLE FOR RELIEF OF MODERATE TO SEVERE ACUTE PAIN

05/07/09

THREE CLINICAL PRESENTATIONS ON TAPENTADOL EXTENDED RELEASE TABLETS FOR CHRONIC PAIN FEATURED AT 2009 AMERICAN PAIN SOCIETY ANNU

05/06/09

Dr. Drew Joins Forces with PriCara^® and the National Association of School Nurses in Program to Prevent Prescript

12/31/08

PRICARA^® RECALLS 50 mcg/hr DURAGESIC^® (fentanyl transdermal system) CII PAIN PATCHES

11/21/08

FDA Approves TAPENTADOL Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain

____________

Home . Our Company . Our Products . Innovation & Research . Therapy Areas
Our Giving . Medical Education . News Center . Contact Us

Your use of the information on this site is subject to the terms of our Legal Notice. Please see our Privacy Policy.

This site is published by PriCara^®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, which is solely responsible for its contents.

This information is intended for the use of our customers, patients and healthcare professionals in the United States only. PriCara^® recognizes that the Internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here may not be appropriate for use outside of the United States. Capitalized product names are trademarks of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

This page was last modified on: Feb 05 2010 at 05:10:25 EDT